Inside Longevity Fund's $250M+ Biotech Investments | LongeVC Founding Partner Sergey Jakimov

In this episode of Innovation Leadership, Jess Larson converses with Sergey Jakimov, the founding partner and managing partner of LongeVC, a venture capital firm specializing in early-stage biotech and longevity startups. Sergey delves into the intricacies of longevity investments, the revolutionary role of AI in drug discovery, and the societal shift towards preventative healthcare. Learn how LongeVC is navigating the complex landscape of age-related diseases and discover why now is a critical moment for longevity science.

Learn more about your ad choices. Visit megaphone.fm/adchoices